Genmab A/S (CPSE:GMAB) commences share repurchases on May 6, 2021, under the program mandated by the shareholders in the Annual General Meeting held on May 22, 2018. As per the mandate, the company is authorized to repurchase up to 10% of its share capital. The authorization will be valid till May 21, 2023. On May 6, 2021, the company announced a share repurchase program. Under the program, the company will repurchase up to 125,000 shares, for DKK 50 million. The program will completed no later than June 2, 2021.